‘USFDA norms haunting Indian pharma’

<br/>The USFDA norms are haunting the pharma sector in India and the sector needs a boost from the Indian government, says the founder and chairman of Wockhardt, Habil Khorakiwala.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved